Skip to main content
Translational Lung Cancer Research logoLink to Translational Lung Cancer Research
. 2022 Nov;11(11):2358–2359. doi: 10.21037/tlcr-2022-8

Erratum to NOTCH alteration in EGFR-mutated lung adenocarcinoma leads to histological small-cell carcinoma transformation under EGFR-TKI treatment

Editorial Office1
PMCID: PMC9742617  PMID: 36519014

This article (1) titled “NOTCH alteration in EGFR-mutated lung adenocarcinoma leads to histological small-cell carcinoma transformation under EGFR-TKI treatment” (doi: 10.21037/tlcr-21-536), unfortunately contains an error in Figure 4. Between Adenocarcinoma and Small Cell Carcinoma in the lower part of the figure, NOTCH expression decreased and ASCL expression increased, which mean the direction of the 2 arrows are reversed. The correct illustration is that, between Adenocarcinoma and Small Cell Carcinoma in the lower part of the figure, the NOTCH arrow points down and the ASCL arrow points up. The corrected Figure 4 can be found below.

Corrected Figure 4:

graphic file with name tlcr-11-11-2358-fig1.jpg

The authors apologize for the oversight.

Click here to view the updated version of the article.

References

  • 1.Koba H, Kimura H, Yoneda T, et al. NOTCH alteration in EGFR-mutated lung adenocarcinoma leads to histological small-cell carcinoma transformation under EGFR-TKI treatment. Transl Lung Cancer Res 2021;10:4161-73. 10.21037/tlcr-21-536 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Translational Lung Cancer Research are provided here courtesy of AME Publications

RESOURCES